For the past 13 years, DIA China Annual Meeting has became the must-attend conference for all life science professionals working in lifecycle drug development, from discovery to marketed use in Asia. It encourages open collaboration by bringing together representatives from the entire spectrum of the life science landscape and facilitating crucial multidisciplinary discussions across several tracks, such as Regulatory Science, Clinical Development, Pharmacovigilance and Drug Safety, Advanced Therapy, Real-Evidence and Data Standards and many more.
DIA China 2022 Meeting will be held in an in-person conference format in Suzhou, will continue to bring the key focuses on Regulatory Innovation, Science & Technology Innovation, and Talent Innovation to forward looking the trends of globalization and localization of drug development & innovation.
DIA 2022 China annual meeting will continue to be located in Suzhou International Expo Center. Based on the dual trend of internationalization of new drug R & D and domestic innovation, the content will comprehensively focus on the three directions of regulatory policy innovation, scientific and technological innovation and talent innovation, and start again by the Bank of Jinji Lake with many colleagues in the field of pharmaceutical research, Looking at the inheritance and innovation of drug R & D globalization in the past 13 years.
